when is the phase 1 trial scheduled to start

can't seem to find any information anywhere?

also what is the trial design going to look like?

what are the value drivers for the next 12 months?

what is the pathway to market?

how is the compassionate use program going? has anyone actually been dosed? when would they expect to see some data?

this company has been listed for four years now yet is still pre clinical, and seemingly not even close to human trials.

where is any data from the animal trials? what side effects were observed. the treatment purportedly targets bacteria but presumably this includes the good as well as the bad. and the good is essential to normal living.

the board includes graham Melrose, his daughter and his grand son (James graham). not exactly independent.

James graham seemingly became the ceo in 2012 fresh out of university. he has a degree in commerce. is he the right ceo for a biotech company trying to enter the clinic? and would the board remove him if he is not (having familial ties?).

just too many unanswered questions for me by a long way. like the idea, but at the moment it has the feel of a lifestyle company..?

happy to be corrected by those who have been following it. as I said I like the concept, just not the almost total lack of any substance.